
Financing - November 14, 2016
Novo Seeds and Almi Invest co-invest in rare disease start-up
Novo Seeds and Almi Invest are to jointly invest up to 6,3 million SEK in rare disease start-up Merozyne Therapeutics dependent on pre-agreed milestones. Merozyne Therapeutics aims to develop a small molecule inhibitor for the treatment of congenital muscular dystrophy (MDC1A). Currently there is no cure for MDC1A, which is caused by an absence of […]

Collaboration - December 23, 2014
Acesion Pharma Gains Investor
Danish biotech company Acesion Pharma, which is actively developing therapeutic treatments for atrial fibrillation (AF), has raised 15.2 million DKK (2.5 million USD) in a new equity investment round. The round includes Boston-based Broadview Ventures as a new investor and current investor Novo Seeds. The company is working on a treatment to prevent the recurrence […]